Patient Guide: Managed Access Program (MAP) to Provide Access to Alpelisib (BYL719) for Patients With PIK3CA-Related Overgrowth Spectrum (PROS)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 0 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04085653
Status: AVAILABLE
Condition: PIK3CA-Related Overgrowth Spectrum (PROS)
Phase: Not Specified

Loading interactive enrollment tools...

The full interactive experience will load momentarily